文献速递帕金森病与运动障碍

运动障碍型脑性瘫痪的临床表现与治疗

Clinical presentation and management of dyskinetic cerebral palsy.
PubMed 文献 · Lancet Neurol · 2017-01-01

运动障碍型脑性瘫痪(DCP)是儿童期严重躯体残疾的常见原因,由基底节或丘脑非进行性病变引起,表现为肌张力调节或运动协调障碍所致的异常姿势或运动。DCP中肌张力障碍和舞蹈手足徐动症常并存,肌张力障碍对日常活动和生活质量影响更大。康复策略为多学科综合干预,口服药物疗效证据有限,神经调控(如鞘内巴氯芬和脑深部电刺激)是有前景的选择。

要点

  • DCP是第二常见的脑瘫类型,由基底节或丘脑非进行性病变引起。
  • 肌张力障碍与舞蹈手足徐动症常共存,肌张力障碍对功能影响更显著。
  • 神经调控(鞘内巴氯芬、脑深部电刺激)是 promising 的治疗选择。

核心结论

  • DCP以肌张力障碍和舞蹈手足徐动症共存为特征,肌张力障碍对日常活动影响更大。
  • 康复策略为多学科综合干预,口服药物疗效证据有限且副作用限制使用。
  • 神经调控干预如鞘内巴氯芬和脑深部电刺激是有前景的治疗选项。

研究设计与样本

  • 本文为综述,检索范围未在摘要中说明。

主要发现

  • DCP是第二常见的脑瘫类型,仅次于痉挛型。
  • DCP通常由基底节或丘脑的非进行性病变引起。
  • 肌张力障碍通常比舞蹈手足徐动症更明显和严重,对日常活动、生活质量和社会参与有重大影响。
  • 两种运动障碍的病理生理机制 largely unknown,新兴假说包括基底节直接和间接通路失衡、感觉处理紊乱和基底节可塑性受损。

临床怎么用

  • 对DCP患者应采用多学科康复策略。
  • 口服药物用于症状缓解时需注意副作用和疗效证据有限。
  • 可考虑神经调控干预如鞘内巴氯芬和脑深部电刺激。

局限性

  • 摘要未报告综述的检索范围和方法学局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cerebral palsy is the most frequent cause of severe physical disability in childhood. Dyskinetic cerebral palsy (DCP) is the second most common type of cerebral palsy after spastic forms. DCP is typically caused by non-progressive lesions to the basal ganglia or thalamus, or both, and is characterised by abnormal postures or movements associated with impaired tone regulation or movement coordination. In DCP, two major movement disorders, dystonia and choreoathetosis, are present together most of the time. Dystonia is often more pronounced and severe than choreoathetosis, with a major effect on daily activity, quality of life, and societal participation. The pathophysiology of both movement disorders is largely unknown. Some emerging hypotheses are an imbalance between indirect and direct basal ganglia pathways, disturbed sensory processing, and impaired plasticity in the basal ganglia. Rehabilitation strategies are typically multidisciplinary. Use of oral drugs to provide symptomatic relief of the movement disorders is limited by adverse effects and the scarcity of evidence that the drugs are effective. Neuromodulation interventions, such as intrathecal baclofen and deep brain stimulation, are promising options.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Monbaliu E, Himmelmann K, Lin JP, et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017. PMID: 28816119. doi:10.1016/S1474-4422(17)30252-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。